SBLI to Offer GRAIL’s Galleri® Multi-Cancer Early Detection Screening Test to Select Policyholders
"GRAIL’s groundbreaking work in early cancer detection aligns perfectly with our mission to foster the health and longevity of our customers.
- "GRAIL’s groundbreaking work in early cancer detection aligns perfectly with our mission to foster the health and longevity of our customers.
- By offering this test, SBLI not only enhances its policy benefits but also affirms our dedication to the well-being of our policyholders."
- The Galleri test will initially be available to select SBLI BOLI policyholders, due to their impact on SBLI’s overall business, their size, and the nature in which the business is underwritten.
- “We applaud SBLI’s leadership for their commitment to health and longevity by offering innovative cutting-edge screening technology and medical advancements like our first-of-its-kind Galleri test.”